Level Four Advisory Services’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-6,605
Closed -$357K 476
2017
Q1
$357K Buy
+6,605
New +$357K 0.04% 380